What CEOs Are Saying: ‘The Consumer Is Under Pressure’

[ad_1] Here’s what leaders from Nasdaq, Microsoft, Tesla and elsewhere said about the economy, inflation and other topics this week. [ad_2] Source link

Jim Cramer picks his standout stocks in 4 bull market industries

[ad_1] CNBC’s Jim Cramer on Wednesday offered investors a list of bull markets he’s identified as companies report quarterly financial results. “Now that we are already one-fifth of the way…

J&J Gets Ready to Break up With Tylenol

[ad_1] Johnson & Johnson’s consumer business was the only division to deliver growth in the fourth quarter. [ad_2] Source link

Stocks making the biggest moves premarket: Bed Bath & Beyond, Verizon, Lululemon and more

[ad_1] A pedestrian walks by a Bed Bath and Beyond store in San Francisco, California. Justin Sullivan | Getty Images Check out the companies making headlines before the bell. Verizon…

Jim Cramer’s Investing Club meeting Tuesday: J&J, Danaher, AMD

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Buy JNJ while it’s…

Johnson & Johnson Fourth-Quarter Earnings Down 25%

[ad_1] The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine. [ad_2] Source link

Stock Futures Slip as Investors Parse Earnings, Await Business-Activity Data

[ad_1] Markets U.S. Markets General Electric, Johnson & Johnson and Microsoft are among companies reporting results Tuesday [ad_2] Source link

WSJ News Exclusive | J&J Slashes Production of Its Unpopular Covid-19 Shot

[ad_1] After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand. The…

Jim Cramer’s Investing Club meeting Tuesday: Microsoft, health care, Emerson Electric

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Reduce exposure to tech…

GE’s Spinoff Deserves Healthy Skepticism

[ad_1] While GE HealthCare will deliver better growth as a stand-alone, the new company’s valuation looks stretched and its leverage is high. [ad_2] Source link